Mandate

Vinge advises Komatsu Forest on acquisition of Log Max

October 23, 2012

Vinge is advising Komatsu Forest AB in connection with the acquisition of Log Max AB and Log Max AB’s US subsidiary Log Max Inc. Komatsu Forest AB is a wholly-owned subsidiary to Komatsu Ltd., who manufactures and sells construction and mining equipment, utilities, forest machines and industrial machinery, with a turnover of approx. USD 21bn. and approx. 44,000 employees, and who is listed inter alia on the Tokyo stock exchange. Log Max, with head office in Grangärde, manufactures and sells equipment for mechanized forestry operations and in particular grapple harvesters - a device that will grip and fell a tree, and cut it to desired lengths.

Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

The Vinge team included partners Carl Gustaf De Geer and Malin Ohlin, and associates Nina Farrahi and Peter Sundgren (M&A), associates Christian Hybinette and Eric Ödling (commercial agreements), partner Marcus Glader and associate Peter Alstergren (EU and competition law), associate Johan Cederblad (environmental law), associate Claes Henriksson (IP law), and associate Emma Lindelöf (employment law).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025